Lv1
10 积分 2025-06-19 加入
A quantitative review of nanotechnology‐based therapeutics for kidney diseases
1天前
待确认
The potential of RNA-based therapy for kidney diseases
1天前
已完结
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial
7天前
已完结
Interleukin-11 and its eminent role in tissue fibrosis: A possible therapeutic target
4个月前
已完结
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
4个月前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
4个月前
已完结
Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity
4个月前
已完结
皖公网安备34019202002308
